Recommendations and Clinical Guidance for Children with Metabolic-associated Liver Disease during the COVID-19 Pandemic
Open Access
- 1 February 2021
- journal article
- editorial
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2020.00137
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- From NAFLD to MAFLD: a “redefining” moment for fatty liver diseaseChinese Medical Journal, 2020
- Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scoresGut, 2020
- Obesity Is a Risk Factor for Greater COVID-19 SeverityDiabetes Care, 2020
- Patients with diabetes are at higher risk for severe illness from COVID-19Diabetes & Metabolism, 2020
- Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysisJournal of Hepatology, 2020
- Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver diseaseMetabolism, 2020
- COVID‐19–Related School Closings and Risk of Weight Gain Among ChildrenObesity, 2020
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- NAFLD in children: new genes, new diagnostic modalities and new drugsNature Reviews Gastroenterology & Hepatology, 2019
- Accelerated Weight Gain Among Children During Summer Versus School Year and Related Racial/Ethnic Disparities: A Systematic ReviewPreventing Chronic Disease, 2014